...
首页> 外文期刊>Neurotoxicity research >Thioperamide, an H receptor antagonist prevents ((3)H)glucose uptake in brain of adult rats lesioned as neonates with 5,7-dihydroxytryptamine.
【24h】

Thioperamide, an H receptor antagonist prevents ((3)H)glucose uptake in brain of adult rats lesioned as neonates with 5,7-dihydroxytryptamine.

机译:Thioperamide是一种H受体拮抗剂,可防止成年大鼠新生的5,7-二羟基色胺使受损大鼠大脑中的((3)H)葡萄糖摄取。

获取原文
获取原文并翻译 | 示例
           

摘要

As a first attempt at exploring an association between histaminergic and serotoninergic neuronal phenotypes in glucose regulation, the influence of the histamine H receptor antagonist thioperamide on glucose uptake by brain was determined in rats in which the serotoninergic innervations of brain was largely destroyed perinatally. Male Wistar rats were initially treated on the 3rd day after birth with the serotoninergic neurotoxin 5,7-dihydroxytryptamine (5,7-DHT) (75 mug icv) or saline vehicle (10 mul icv). At 8 weeks lesioned and control rats were terminated in order to validate the effectiveness of 5,7-DHT: reduction in 5-HT and 5-HIAA by 83-91% and 69-83% in striatum, frontal cortex, and hippocampus (HPLC/ED method). Other groups of rats were pretreated with thioperamide (5.0 mg/kg ip) or saline vehicle 60 min prior to 6-[(3)H]-D-glucose (500 muCi/kg ip). Fifteen-min later rats were decapitated and brains were excised and dissected to remove frontal cortex, striatum, hippocampus, thalamus/hypothalamus, pons, and cerebellum. Liquid scintillation spectroscopy was used to determine that [(3)H]glucose uptake, which was enhanced in 5,7-DHT lesioned rats in cortex (by 88%), hippocampus, thalamus/hypothalamus, pons and cerebellum (each by 47-56%), and in striatum (by 35%). In contrast, thioperamide prevented the enhancement in [(3)H]glucose uptake in all brain regions of 5,7-DHT neonatally lesioned rats; and [(3)H]glucose levels were significantly different in all brain regions (except thalamus/hypothalamus) in thioperamide-versus saline-treated rats. These findings indicate a functional association between histaminergic and serotoninergic systems in brain in relation to glucose regulation.
机译:作为探索组胺能和5-羟色胺能神经元表型之间葡萄糖调节相关性的首次尝试,在大鼠中确定了组胺H受体拮抗剂硫代过酰胺对脑葡萄糖摄取的影响,其中大鼠的5-羟色胺能神经支配在围产期被破坏。雄性Wistar大鼠在出生后的第3天最初接受5-羟色胺能神经毒素5,7-二羟基色胺(5,7-DHT)(75杯icv)或生理盐水(10 mul icv)的治疗。在8周时,将病变大鼠和对照组的大鼠处死,以验证5,7-DHT的有效性:纹状体,额叶皮层和海马体中的5-HT和5-HIAA降低83-91%和69-83%( HPLC / ED方法)。在6-[(3)H] -D-葡萄糖(500 muCi / kg ip)之前60分钟,用硫代过酰胺(5.0 mg / kg ip ip)或生理盐水载体预处理其他组大鼠。 15分钟后将大鼠断头,切除大脑并解剖,以去除额叶皮层,纹状体,海马,丘脑/下丘脑,脑桥和小脑。液体闪烁光谱法用于确定[(3)H]葡萄糖摄取,在皮质,海马,丘脑/下丘脑,脑桥和小脑(每个47- 56%)和纹状体(减少35%)。相反,硫代过酰胺阻止了5,7-DHT新生病变大鼠的所有脑区域中[(3)H]葡萄糖摄取的增加;和[(3)H]葡萄糖水平在硫代过磷酸酰胺对盐水处理的大鼠的所有脑区域(丘脑/下丘脑除外)中均显着不同。这些发现表明脑中组胺能和5-羟色胺能系统之间的功能关联与葡萄糖调节有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号